Priority work packages
| Work package number | Research and development work package | Objective(s) |
|---|---|---|
| 1 | Requirements for field medical care | Develop reference guides with alignment to real world clinical needs. |
| Guide design and efficacy of proposed technology and innovations. | ||
| 2 | Additive layer manufacture capability | Evaluate field deployable ALM processes for custom medical devices with lean design. |
| Focus on wound care, surgical devices, immobilisation and protection. | ||
| 3 | Cell and tissue therapy manufacturing capability | Identify elements of PCP and supply chain where CaTT can have most benefit. |
| Feasibility and therapeutic benefit for casualty stabilisation, tissue reconstruction and sustainability. Costs of integration into the PCP. | ||
| 4 | Clinical fluids manufacturing capability | Demonstrate capability to produce clinical fluids including intravenous solutions with supply at or near to point of injury/illness. |
| Reduction of logistical burden and improving freedom of movement. | ||
| 5 | Bio-pharmaceutical manufacturing capability | Advance the development of miniaturised portable manufacturing device platforms and technologies capable of produce small-molecule active pharmaceutical ingredients and therapeutic proteins. |
| Reduced stockpiling and logistical burden. Rapid treatment at or near to point of injury/illness. | ||
| 6 | Innovation, assessment and adoption for field medical care | To integrate learning from all research themes. Systematic evaluation and validation of medical innovation route maps. Business case and investment guidance for innovators and technology acquisition staff. |
ALM = additive layer manufacture; CaTT = cell and tissue therapy; PCP = patient care pathway.